Goodwin Advises Enfusion in $1.5 Billion Acquisition by Clearwater Analytics
January 14, 2025
January 14, 2025
BOSTON, Massachusetts, Jan. 14 -- Goodwin, a law firm, issued the following news release:
The Goodwin Public M&A and Technology teams advised Enfusion (NYSE: ENFN), a leader in software-as-a-service (SaaS) solutions for the investment management and hedge fund industry, on its sale to Clearwater Analytics (NYSE: CWAN). The purchase price is $11.25 per share, delivered in an approximately equal mix of cash and stock. Additionally, Clearwater will pay $30 million to terminate Enfu . . .
The Goodwin Public M&A and Technology teams advised Enfusion (NYSE: ENFN), a leader in software-as-a-service (SaaS) solutions for the investment management and hedge fund industry, on its sale to Clearwater Analytics (NYSE: CWAN). The purchase price is $11.25 per share, delivered in an approximately equal mix of cash and stock. Additionally, Clearwater will pay $30 million to terminate Enfu . . .